Skip to content
naulon

Not checkedNot checked for notices yet.

Ceoliac disease

Troncone Riccardo

Clinical and Translational Allergy · 2011

doi:10.1186/2045-7022-1-s1-s33 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Celiac disease is a T-cell mediated chronic inflammatory disorder with an autoimmune component.Altered processing by intraluminal enzymes, changes in intestinal permeability, and activation of innate immunity mechanisms seems to precede the activation of the adaptive response.Significant progress has been made in the understanding of the cellular and molecular basis of CD and in the consequent identification of potential targets for therapy.Recently, it has been shown that gliadin peptides are highly resistant to digestive processing by pancreatic and brush border proteases.Enzyme supplement therapy using bacterial prolyl endopeptidases has been proposed to destroy T-cell multipotent epitopes.The identification of T-cell stimulatory gliadin sequences is important.Breeding programs and/or transgenic technology may lead to production of wheat that is devoid of biologically active peptide sequences.The identification of specific epitopes may also provide a target for immunomodulation of antigenic peptides.Other promising areas include preventing gliadin presentation to T cells by blocking HLA binding sites, use of tTG inhibitors, and assessing IL-10 as a tool for promoting tolerance.However, evidence that gluten toxicity is not dependent only on T-cell recognition is growing; activation of innate immunity has been demonstrated and antibodies to IL-15 proposed, particularly in refractory sprue because of the IEL activating role of IL-15.However, one should realize that CD is a benign disease and dietary treatment is safe, although strenuous An immunomodulatory approach will need to have a safety profile equivalent to that of the GFD, but with the advantage of increased compliance.Another area of important changes for CD concerns the diagnostic protocol.In 1990 ESPGHAN has revised its former diagnostic criteria laid down in 1970.The two requirements mandatory for the diagnosis of celiac disease (CD) remain: 1) the finding of villous atrophy with

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.